137 related articles for article (PubMed ID: 4154597)
1. [General immunogenesis after oral uptake of killed Pertussis bacteria].
Hof H; Finger H
Zentralbl Bakteriol Orig A; 1974; 227(1-4):282-8. PubMed ID: 4154597
[No Abstract] [Full Text] [Related]
2. Studies on the immunizing capacity of orally administered particulate antigens. I. The efficiency of killed Bordetella pertussis cells.
Hof H; Finger H; Körner L; Milcke L
Zentralbl Bakteriol Orig A; 1975; 230(2):210-22. PubMed ID: 167535
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of orally administered Bordetella pertussis vaccine in mice.
Hof H; Finger H; Körner L; Milcke L
Dev Biol Stand; 1976; 33():47-53. PubMed ID: 182602
[TBL] [Abstract][Full Text] [Related]
4. [Construction of the genetically attenuated bacteria Bordetella pertussis devoid of dermonecrotic toxin activity and producing modified nontoxic pertussis toxin form].
Siniashina LN; Siniashina LS; Semin EG; Amelina IP; Karataev GI
Mol Gen Mikrobiol Virusol; 2010; (3):31-6. PubMed ID: 20886687
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results with an oral application of killed Purtussis bacteria in newborn infants.
Stickl H; Schweier P; van Thiel D
Dev Biol Stand; 1976; 33():54-6. PubMed ID: 182603
[TBL] [Abstract][Full Text] [Related]
6. Induction of humoral immunity in response to immunization with recombinant Mycobacterium bovis BCG expressing the S1 subunit of Bordetella pertussis toxin.
Medeiros MA; Armôa GR; Dellagostin OA; McIntosh D
Can J Microbiol; 2005 Dec; 51(12):1015-20. PubMed ID: 16462859
[TBL] [Abstract][Full Text] [Related]
7. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
Mallaley PP; Halperin SA; Morris A; MacMillan A; Lee SF
Can J Microbiol; 2006 May; 52(5):436-44. PubMed ID: 16699568
[TBL] [Abstract][Full Text] [Related]
8. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route.
Li R; Lim A; Alonso S
Bioeng Bugs; 2011; 2(6):315-9. PubMed ID: 22067832
[TBL] [Abstract][Full Text] [Related]
9. A live vaccine against pertussis.
Vesselinova-Jenkins CK
Dev Biol Stand; 1985; 61():517-24. PubMed ID: 3835083
[TBL] [Abstract][Full Text] [Related]
10. Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of concept.
Gavillet BM; Mondoulet L; Dhelft V; Eberhardt CS; Auderset F; Pham HT; Petre J; Lambert PH; Benhamou PH; Siegrist CA
Vaccine; 2015 Jul; 33(30):3450-5. PubMed ID: 26067183
[TBL] [Abstract][Full Text] [Related]
11. [Antigens of Bordetella pertussis and their repercussion in immunization programs against whooping cough].
Casal Lombos J
Rev Sanid Hig Publica (Madr); 1971 May; 45(5):575-87. PubMed ID: 4330706
[No Abstract] [Full Text] [Related]
12. [New vaccines against Bordetella Pertussis].
Eskola J; Mertsola J
Duodecim; 1996; 112(13):1137-8. PubMed ID: 10596079
[No Abstract] [Full Text] [Related]
13. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells.
Conway MA; Madrigal-Estebas L; McClean S; Brayden DJ; Mills KH
Vaccine; 2001 Feb; 19(15-16):1940-50. PubMed ID: 11228364
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the efficacy of parenteral and enteral pertussis immunization in the rabbit (author's transl)].
Höfler KH; Binder B; Koch M
Wien Klin Wochenschr; 1977 May; 89(11):386-9. PubMed ID: 878481
[TBL] [Abstract][Full Text] [Related]
15. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
[TBL] [Abstract][Full Text] [Related]
16. [Developmental trends in pertussis vaccines].
Milleck J; Ocklitz HW
Z Arztl Fortbild (Jena); 1971 Dec; 65(24):1285-7. PubMed ID: 4335598
[No Abstract] [Full Text] [Related]
17. [Immunogenic value of the diphtheria-tetanus-pertussis trivaccine depending on the quantitative variations of its antigenic components. IV. Immunogenic properties of the pertussis compound].
Andreescu V; Caffé I; Marion M; Pozsgi N; Stănică E; Stoian C; Kranzdorf H
Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):487-92. PubMed ID: 4328575
[No Abstract] [Full Text] [Related]
18. Subcellular fractions for immunizing against pertussis.
Parker CD; Field LH; Berry LJ; Manclark C
Dev Biol Stand; 1978; 41():23-9. PubMed ID: 223910
[TBL] [Abstract][Full Text] [Related]
19. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.
Reynolds E; Walker B; Xing D; Southern J; Asokanathan C; Dagg B; Corbel M; Miller E
Vaccine; 2006 Apr; 24(16):3248-57. PubMed ID: 16480794
[TBL] [Abstract][Full Text] [Related]
20. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.
Denoël P; Godfroid F; Guiso N; Hallander H; Poolman J
Vaccine; 2005 Nov; 23(46-47):5333-41. PubMed ID: 16054273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
